Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.15.6429

Dimethylnitrosamine-Induced Reduction in the Level of Poly-ADP-Ribosylation of Histone Proteins of Blood Lymphocytes - a Sensitive and Reliable Biomarker for Early Detection of Cancer  

Kma, Lakhan (Cancer and Radiation Countermeasures Unit, Department of Biochemistry, North-Eastern Hill University)
Sharan, Rajeshwar Nath (Radiation and Molecular Biology Unit, Department of Biochemistry, North-Eastern Hill University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.15, 2014 , pp. 6429-6436 More about this Journal
Abstract
Poly-ADP-ribosylation (PAR) is a post-translational modification of mainly chromosomal proteins. It is known to be strongly involved in several molecular events, including nucleosome-remodelling and carcinogenesis. In this investigation, it was attempted to evaluate PAR level as a reliable biomarker for early detection of cancer in blood lymphocyte histones. PAR of isolated histone proteins was monitored in normal and dimethylnitrosamine (DMN)-exposed mice tissues using a novel ELISA-based immuno-probe assay developed in our laboratory. An inverse relationship was found between the level of PAR and period of DMN exposure in various histone proteins of blood lymphocytes and spleen cells. With the increase in the DMN exposure period, there was reduction in the PAR level of individual histones in both cases. It was also observed that the decrease in the level of PAR of histones resulted in progressive relaxation of genomic DNA, perhaps triggering activation of genes that are involved in initiation of transformation. The observed effect of carcinogen on the PAR of blood lymphocyte histones provided us with a handy tool for monitoring biochemical or physiological status of individuals exposed to carcinogens without obtaining biopsies of cancerous tissues, which involves several medical and ethical issues. Obtaining blood from any patient and separating blood lymphocytes are routine medical practices involving virtually no medical intervention, post-procedure medical care or trauma to a patient. Moreover, the immuno-probe assay is very simple, sensitive, reliable and cost-effective. Therefore, combined with the ease of preparation of blood lymphocytes and the simplicity of the technique, immuno-probe assay of PAR has the potential to be applied for mass screening of cancer. It appears to be a promising step in the ultimate goal of making cancer detection simple, sensitive and reliable in the near future.
Keywords
Poly-ADP-ribosylation; carcinogenesis; DMN; immuno-probe; blood lymphocytes; histones;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Humphries JM, Penno MA, Weiland F et al (2014). Identification and validation of novel candidate protein biomarkers for the detection of human gastriccancer. Biochim Biophys Acta, 1844, 1051-8.   DOI   ScienceOn
2 Kalmar-Nagy K, Degrell P, Szabo A et al (2013). PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade. PLoS One, 8, 81928-6.   DOI
3 Khan S, Jutzy JM, Valenzuela MM et al (2012). Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS One, 7, 46737-5.   DOI   ScienceOn
4 Kma L, Sharan RN (2006). In vivo exposure of Swiss albino mice to chronic low dose of dimethylnitrosamine (DMN) lowers poly-ADP-ribosylation (PAR) of bone marrow cell and blood lymphocyte proteins. Mol Cell Biochem, 288, 143-9.   DOI
5 Kma L, Sharan RN (2008). Chronic exposure of mice to aqueous extract of betel nuts (AEBN) inhibits poly-ADP-ribosylation (PAR) of total cellular proteins as well as histone H1 protein. Canadian J Pure and Applied Sci, 2, 123-8.
6 Kondo T (2014). Inconvenient truth: cancer biomarker development by using proteomics. Biochim Biophys Acta, 1844, 861-5.   DOI   ScienceOn
7 Long CA, Boulom V, Albadawi H et al (2013). Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes. Ann Surg, 258, 1087-5.   DOI
8 Margison GP, O'Conner PJ (1979). In 'Chemical Carcinogens and DNA', Ed Grover PL. CRC Press, Baltimore.
9 Marzinke MA, Choi CH, Chen L et al (2013). Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery. Mol Cell Proteomics, 12, 356-68.   DOI
10 Moto M, Umemura T, Okamura M et al (2006). Possible involvement of oxidative stress in dicyclanil-induced hepatocarcinogenesis in mice. Arch Toxicol, 80, 694-2.   DOI
11 Osada T, Ryden AM, Masutani M (2013). Poly(ADPribosylation) regulates chromatin organization through histone H3 modification and DNA methylation of the first cell cycle of mouse embryos. Biochem Biophys Res Commun, 434, 15-1.   DOI   ScienceOn
12 Ozaki Y, Matsui H, Asou H et al (2012). Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome maturation. Mol Cell, 47, 694-06.   DOI   ScienceOn
13 Pariat T, Sharan RN (2002). Role of mouse spleen cell HMG proteins and their poly ADP-ribosylation in betel nut induced carcinogenesis. Indian J Biochem, 39, 130-5.
14 Redon CE, Nakamura AJ, Zhang YW et al (2010). Histone gammaH2AX and poly(ADP-ribose) as clinical pharmacodynamic biomarkers. Clin Cancer Res, 16, 4532-2.   DOI   ScienceOn
15 Sala A, La Rocca G, Burgio G et al (2008). The nucleosomeremodeling ATPase ISWI is regulated by poly-ADPribosylation. PLoS Biol, 6, 252-8.   DOI   ScienceOn
16 Schwartz DC, Cantor CR (1984). Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis. Cell, 37, 67-5.   DOI   ScienceOn
17 Sharan RN, Devi BJ, Humtsoe JO, Saikia JR, Kma L (2005). Detection and quantification of poly-ADP-ribosylated proteins of spleen and liver tissues of mice in vivo by slot and Western blot immunoprobing using polyclonal antibody against mouse ADP-ribose polymer. Mol Cell Biochem, 278, 213-1.   DOI
18 Sigari N, Mohsenpour B, Nikkhoo B et al (2014). Determination of the best prognostic value of serum tumor markers in patients with suspected lungcancer in an Iranian population. Clin Lab, 60, 23-7.
19 Stephan F, Marsman G, Bakker LM et al (2014). Cooperation of factor VII-activating protease and serum DNase I in the release of nucleosomes from necrotic cells. Arthritis Rheumatol, 66, 686-3.   DOI   ScienceOn
20 Soond SM, Smith PG, Wahl L et al (2013). Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets incancer. Biochim Biophys Acta, 1832, 2127-5.   DOI   ScienceOn
21 Suradej B, Pata S, Kasinrerk W, Cressey R (2013). Glucosidase II exhibits similarity to the p53 tumor suppressor in regards to structure and behavior in response to stress signals: a potential novel cancer biomarker. Oncol Rep, 30, 2511-9.
22 Tago Y, Yamano S, Wei M et al (2013). Novel medium-term carcinogenesis model for lung squamous cell carcinoma induced by N-nitroso-tris-chloroethylurea in mice. Cancer Sci, 104, 1560-6.   DOI   ScienceOn
23 Taguchi A, Hanash SM (2013). Unleashing the power of proteomics to develop blood-based cancer markers. Clin Chem, 59, 119-6.   DOI   ScienceOn
24 Ueda K, Tatsuguchi A, Saichi N et al (2013). Plasma low-molecular-weight proteome profiling identified neuropeptide-Y as a prostate cancer biomarker polypeptide. J Proteome Res, 12, 4497-6.   DOI   ScienceOn
25 van der Bilt AR, Terwisscha van Scheltinga AG, Timmer-Bosscha H et al (2012). Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model. Clin Cancer Res, 18, 6306-4.   DOI
26 Villani P, Eleuteri P, Grollino MG et al (2010). Sperm DNA fragmentation induced by DNAse I and hydrogen peroxide: an in vitro comparative study among different mammalian species. Reproduction, 140, 445-2.   DOI   ScienceOn
27 Yuan K, Sun Y, Zhou T, McDonald J, Chen Y (2013). PARP-1 regulates resistance of pancreatic cancer to TRAIL therapy. Clin Cancer Res, 19, 4750-9.   DOI   ScienceOn
28 Wang X, Zhang A, Sun H (2013). Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma. Hepatology, 57, 2072-7.   DOI   ScienceOn
29 West MHP, Bonner WM (1980). Histone 2A, a heteromorphous family of eight protein species. Biochemistry, 19, 3238-5.   DOI   ScienceOn
30 Yang Y, Toy W, Choong LY et al (2012). Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications inmolecular imaging. J Proteome Res, 11, 5736-47.
31 Asubel F, Brent R, Kingston RE et al (1995). Short protocols in molecular biology, third edition, John Wiley and Sons, Inc. USA.
32 Althaus FR, Richter C (1987). Poly (ADP-ribose) biosynthesis. In 'ADP-ribosylation of proteins: enzymology and biological significance, molecular biology biochemistry and biophysics', ed solioz m. springer-verlag, New York pp 1-230.
33 Alvarez-Chaver P, Otero-Estevez O, Paez de la Cadena M et al (2014). Proteomics for discovery of candidate colorectal cancer biomarkers. World J Gastroenterol, 20, 3804-24.   DOI   ScienceOn
34 Apostolov EO, Soultanova I, Savenka A et al (2009). Deoxyribonuclease I is essential for DNA fragmentation induced by gamma radiation in mice. Radiat Res, 172, 481-92.   DOI   ScienceOn
35 Bao H, Burke PA, Huang J et al (2013). Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study. PLoS One, 8, 58557-4.   DOI
36 Burton K (1968). Determination of DNA concentration with diphenylamine. Methods Enzymol, 12, 163-6.   DOI
37 Behrens T, Bonberg N, Casjens S, Pesch B, Bruning T (2014). A practical guide to epidemiological practice and standards in the identification and validation of diagnostic markers using a bladder cancer example. Biochim Biophys Acta, 1844, 145-5.   DOI   ScienceOn
38 Binu S, Soumya SJ, Kumar VB, Sudhakaran PR (2012). Poly-ADP-ribosylation of vascular endothelial growth factor and its implications on angiogenesis. Adv Exp Med Biol, 749, 269-8.   DOI   ScienceOn
39 Blake JA, Bult CJ, Eppig JT, Kadin JA, Richardson JE (2014). The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res, 42, 810-7.   DOI   ScienceOn
40 Cheung WY, Gale MD (1990). The isolation of high molecular weight DNA from wheat, barley and rye for analysis by pulse-fieldgel electrophoresis. Plant Mol Biol, 14, 881-8.   DOI
41 Chikan NA, Shabir N, Shaff S, Mir MR, Patel TN (2012). N-nitrosodimethylamine in the Kashmiri diet and possible roles in the high incidence of gastrointestinal cancers. Asian Pac J Cancer Prev, 13, 1077-9.   과학기술학회마을   DOI   ScienceOn
42 Chiou SH, Jiang BH, Yu YL et al (2013). Poly(ADP-ribose) polymerase 1 regulates nuclear reprogramming and promotes iPSC generation without c-Myc. J Exp Med, 210, 85-98.   DOI   ScienceOn
43 De Souza Setubal Destro MF, Bitu CC, Zecchin KG et al (2010). Overexpression of HOXB7 homeobox gene in oral cancer induces cellular proliferation and is associated with poor prognosis. Int J Oncol, 36, 141-9.
44 Feng X, Koh DW (2013). Inhibition of poly(ADP-ribose) polymerase-1 or poly(ADP ribose) glycohydrolase individually, but not in combination, leads to improved chemotherapeutic efficacy in HeLa cells. Int J Oncol, 42, 749-6.
45 Devi BJ, Sharan RN (2006). Progressive reduction in poly-ADPribosylation of histone proteins during Dalton's lymphoma induced ascites tumorigenesis in mice. Cancer Lett, 238, 135-1.   DOI   ScienceOn
46 Dona F, Chiodi I, Belgiovine C et al (2013). Poly (ADPribosylation) and neoplastic transformation: effect of PARP inhibitors. Curr Pharm Biotechnol, 14, 524-36.   DOI
47 Fauzee NJ, Pan J, Wang YL (2010). PARP and PARG inhibitors--new therapeutic targets in cancer treatment. Pathol Oncol Res, 16, 469-8.   DOI
48 Fontan-Lozano A, Suarez-Pereira I, Horrillo A et al (2010). Histone H1 poly[ADP]-ribosylation regulates the chromatin alterations required for learning consolidation. J Neurosci, 30, 13305-3.   DOI   ScienceOn
49 Harbeck N, Sotlar K, Wuerstlein R, Doisneau-Sixou S (2014). Molecular and protein markers for clinical decision making in breast cancer: today and tomorrow. Cancer Treat Rev, 40, 434-4.   DOI   ScienceOn
50 Hensing TA, Salgia R (2013). Molecular biomarkers for future screening of lung cancer. J Surg Oncol, 108, 327-3.   DOI   ScienceOn
51 Hong Z, Bi A, Chen D et al (2014). Activation of hedgehog signaling pathway in human non-small cell lung cancers. Pathol Oncol Res. 9.
52 Huang YJ, Frazier ML, Zhang N, Liu Q, Wei C (2014). Reversephase protein array analysis to identify biomarker proteins in human pancreatic cancer. Dig Dis Sci, 59, 968-5.   DOI   ScienceOn
53 Luna Coronell JA, Syed P, Sergelen K, Gyurjan I, Weinhausel A (2012). The current status of cancer biomarker research using tumour-associated antigens for minimal invasive and early cancer diagnostics. J Proteomics, 76, 102-15.   DOI   ScienceOn